Do multivitamin supplements attenuate the risk for diabetes-associated birth defects?

Pediatrics

Volumn 111, Issue 5 II, 2003, Pages 1146-1151

  Correa, Adolfo ^a   Botto, Lorenzo ^b   Liu, Yecai ^b   Mulinare, Joseph ^b   Erickson, J David ^b  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b NONE

Author keywords

Birth defects; Central nervous system defects; Congenital heart defects; Diabetes; Multivitamin supplements; Prevention

Indexed keywords

MULTIVITAMIN;

ANENCEPHALUS; ANUS ATRESIA; ARTICLE; BIRTH DEFECT; CLEFT LIP PALATE; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM MALFORMATION; FALLOT TETRALOGY; HEART SEPTUM DEFECT; HUMAN; HYDROCEPHALUS; INFANT; MAJOR CLINICAL STUDY; MATERNAL DISEASE; NERVOUS SYSTEM MALFORMATION; NEURAL TUBE DEFECT; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PYLORUS STENOSIS; RESPIRATORY TRACT MALFORMATION; RISK ASSESSMENT; SPINA BIFIDA; VITAMIN INTAKE;

ABNORMALITIES; ADULT; CASE-CONTROL STUDIES; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INFANT, NEWBORN; PRECONCEPTION CARE; PREGNANCY; PREGNANCY IN DIABETICS; PRENATAL CARE; RISK FACTORS; VITAMINS;

EID: 0037626147     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Pederson LM, Tygstrup I, Pederson J. Congenital malformations in newborn infants of diabetic women. Lancet. 1964;1:1124-1126
2. Kucera J. Rate and type of congenital anomalies among offspring of diabetic mothers. J Reprod Med. 1971;7:61-70
3. Chung CS, Myrianthopolous NC. Factors affecting risks of congenital malformations. II. Effect of maternal diabetes on congenital malformations. Birth Defects Orig Artic Ser. 1975;11:23-38
4. Mills JL. Malformations in infants of diabetic mothers. Teratology. 1982; 25:385-394
5. Martinez-Frias ML. Epidemiological analysis of outcomes of pregnancy in diabetic mothers: identification of the most characteristic and most frequent congenital anomalies. Am J Med Genet. 1994;51:108-113
6. Becerra J, Khoury JM, Cordero JF, Erickson JD. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics. 1990;85:1-9
7. Ferencz C, Loffredo CA, Correa-Villaseñor A, Wilson PD. Genetic and Environmental Risk Factors Of Major Cardiovascular Malformations: The Baltimore-Washington Infant Study, 1981-1989. Perspectives in Pediatric Cardiology, V. Armonk, NY: Futura Publishing Company; 1997
8. 1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med. 1981;304:1331-1334
9. 1c and risk for major malformation and spontaneous abortion in diabetic pregnancy. Br Med J. 1984;289:345-346
10. Key TC, Giuffrida R, Moore TR. Predictive value of early pregnancy glycohemoglobin in the insulin-treated diabetic patient. Am J Obstet Gynecol. 1987;156:1096-2000
11. Cockroft DL, Coppola PT. Teratogenic effects of excess glucose on head-fold rat embryos in culture. Teratology. 1977;16:141-146
12. Sadler TW. Effects of maternal diabetes on early embryogenesis: II. Hyperglycemia induced exencephaly. Teratology. 1980;21:349-356
13. Reece EA, Homko CJ, Wu Y-K. Multifactorial basis of the syndrome of diabetic embryopathy. Teratology. 1996;54:171-182
14. Viana M, Herrera, Bonet B. Teratogenic effects of diabetes mellitus in the rat. Prevention by vitamin E. Diabetologia. 1996;39:1041-1046
15. Reece EA, Wu Y-K. Prevention of diabetic embryopathy in offspring of diabetic rats with use of a cocktail of deficient substrates and an antioxidant. Am J Obstet Gynecol. 1997;176:790-798
16. Siman CM, UJ Eriksson. Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats. Diabetes. 1997;46:1054-1061
17. Siman CM, Gittenberger-De Groot AC, Wisse B, Eriksson UJ. Malformations in offspring of diabetic rats: morphometric analysis of neural crest-derived organs and effects of maternal vitamin E treatment. Teratology. 2000;61:355-367
18. Smithells RW, Nevin NC, Seller MJ, et al. Further experience of vitamin supplementation for prevention of neural tube defect recurrence. Lancet. 1983;1:1027-1031
19. Berry RJ, Li Z, Erickson JD, et al. Prevention of neural tube defects with folic acid in China. China-US Collaborative Project for Neural Tube Defect Prevention. N Engl J Med. 1999;341:1485-1490
20. Czeizel AE, Duda I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992;327:1832-1835
21. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991; 338:131-137
22. Shaw GM, Lammer EJ, Wasserman CR, O'Malley CD, Tolarova MM. Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet. 1995;356:393-396
23. Tolarova M, Harris J, Louik C, Shapiro S, Mitchell AA. Multivitamin supplementation and risk of birth defects. Am J Epidemiol. 1999;150: 675-682
24. Shaw GM, O'Malley CD, Wasserman CR, Tolarova MM, Lamer EJ. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet. 1995;536-545
25. Botto L, Khoury MJ, Mulinare J, Erickson JD. Periconceptional multivitamin use and the occurrence of conotruncal heart defects from a population-based, case-control study. Pediatrics. 1996;98:911-917
26. Czeizel AE. Prevention of congenital abnormalities by periconceptional multivitamin supplementation. Br Med J 1993;306:1645-1648
27. Czeizel AE. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet. 1996;62:179-183
28. Erickson JD, Mulinare J, McClain PW, et al. Vietnam veterans' risk for fathering babies with birth defects. JAMA. 1984;252:903-912
29. Erickson JD, Mulinare J, McClain OW, et al. Vietnam Veterans' Risks for Fathering Babies with Birth Defects. Atlanta, GA: Centers for Disease Control; 1984
30. Clark EB. Pathogenetic mechanisms of congenital cardiovascular malformations revisited. Semin Perinatol. 1996;20:465-472
31. Mehta CR, Patel NR. A network algorithm for performing Fisher's test in r x c contingency tables. J Am Star Assoc. 1983;78:427-434
32. Hirji KF, Mehta CR, Patel NR. Exact inference for matched case-control studies. Biometrics. 1988;44:803-804
33. Baker L, Egler JM, Klein SH, Goldman AS. Meticulous control of diabetes during organogenesis prevents congenital lumbosacral defects in rats. Diabetes. 1981;30:955-959
34. Pregnancy outcomes in the Diabetes Control and Complications Trial. Am J Obstet Gynecol. 1996;174:1343-1353
35. Myers M, Li S, Correa A, et al. Prevention of imperforate anus with folic acid in China. Am J Epidemiol. 2001;154:1051-1056
36. Phelan SA, Ito M, Locken MR. Neural tube defects in embryos of diabetic mice: role of the Pax-3 gene and apoptosis. Diabetes. 1997;46: 1189-1197
37. Eriksson UJ, Siman CM. Pregnant diabetic rats fed the antioxidant butylated hydroxytoluene show decreased occurrence of malformations in offspring. Diabetes. 1996;45:1497-1502
38. Hagay ZJ, Weiss Y, Zusman I, et al. Prevention of diabetes-associated embryopathy by overexpression of the free radical scavenger copper zinc superoxide dismutase in transgenic mouse embryos. Am J Obstet Gynecol. 1995;173:1036-1041
39. Centers for Disease Control and Prevention. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Morb Mortal Wkly Rep 1992;41:1-7
40. American Diabetes Association. Preconception care of women with diabetes. Diabetes Care. 2001;24:S66-S79